Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: sites default files Rare Disease Webinar Slides Final Feb 27 pdf
… Webinar: Economic Modelling Challenges in Rare Diseases Share … 2019 Watch the recording When seeking approval for rare disease products, demonstrating value for therapies can be a …
… leaders, we can help you with: Burden/cost of Illness Disease prevalence and incidence Treatment patterns, impact, … Depending upon your patient population demographics, disease areas, data types, geography, timeline, and budget, …
HTA and Reimbursement Submissions The reimbursement environment is constantly changing. Requirements vary between markets and need coordination across multiple areas to produce high-quality results. To help you achieve market access, our experts across …
… Webinar: Beyond Controlling for Confounding Share on: Thursday, September 27, 2018, 10 - 11am Watch the Recording Going One Step … to fill the gaps. For example, if we suspect a drug has a rare toxicity after years of being marketed, we may resort to …
… are relative based on a person’s understanding of their disease state, disease progression, and available therapies, so market … numerous recruitment techniques including working with sites, patient advocacy groups, patient panels, and social …
… Webinar: Strategic Planning for Orphan Drugs Share on: … Generation Planning When developing new products to treat rare diseases, it is particularly challenging to demonstrate … for those who wish to leverage evidence generation in rare disease research to support communications to healthcare …
… Webinar: HEOR Evidence for Emergent Infectious Diseases Share … have to be developed in the context of a rapidly evolving disease landscape. As we return to standard reimbursement … from a continually changing environment. In this 1-hour webinar, we’ll look at the opportunities and challenges that …
… Rare Diseases A Wealth of Experience We have collaborated with our clients on projects to research rare diseases, rare disease treatment, and complications and comorbidities of …
… include: Highlights and Overview Product Information and Disease Description Clinical Evidence Economic Information … which allow your chosen clinical expert to present key disease and unmet need evidence to US health care decision … include: Executive Summary Product Information and Disease Description Clinical Evidence Economic Value and …
… of the full exercise and will provide a brief report, slides, or summary memorandum, along with a set of …